Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized phase III trial of 1 vs 2 courses BEP adjuvant chemotherapy in high-risk non-seminomatous germ cell tumors (AH 10/04)
DRKS00003520Phase 3Recruiting
- Sponsor
- Deutsche Krebshilfe
- Start
- Apr 2012
- Modality
- Small Molecules
- Countries
- 11
01
Overview
Phase 3, randomised trial of bleomycin, etoposide and cisplatin in Germ Cell Testicular Cancer and testicular cancer (2 arms), sponsored by Deutsche Krebshilfe. Started Apr 2012; status: recruiting.
02
Drugs
bleomycinetoposidecisplatin
03
Conditions
Germ Cell Testicular Cancertesticular cancer
Beyond the preview
Go deeper on DRKS00003520.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00003520.